|Articles|June 21, 2023
Mass Spectrometry Imaging: Top 8 benefits in oncology drug discovery and development
Author(s) Pyxant
Mass spectrometry imaging (MSI) is beneficial in early development and murine models across many therapeutic areas. This technique is especially suited for oncology due to the availability of tissue.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
PharmTech Weekly News Roundup – Week of December 1, 2025
3
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
4
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
5
